HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jaroslaw D Kasprzak Selected Research
Jaroslaw D Kasprzak Research Topics
Disease
3
ST Elevation Myocardial Infarction
01/2020 - 02/2009
3
Thrombosis (Thrombus)
12/2017 - 06/2007
3
Hemorrhage
01/2016 - 08/2013
3
Acute Coronary Syndrome
08/2014 - 08/2013
2
Heart Failure
01/2023 - 03/2017
2
Coronary Artery Disease (Coronary Atherosclerosis)
08/2021 - 10/2013
2
Infarction (Infarctions)
01/2016 - 02/2009
2
Rupture
01/2016 - 03/2010
2
Myocardial Infarction
08/2014 - 02/2009
2
Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
10/2003 - 04/2002
1
Pulmonary Arterial Hypertension
10/2022
1
COVID-19
10/2022
1
Disease Progression
10/2022
1
Aortic Valve Stenosis (Aortic Stenosis)
11/2021
1
Coronary Vasospasm (Coronary Artery Vasospasm)
08/2021
1
Tetralogy of Fallot (Fallot Tetralogy)
08/2021
1
Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
08/2021
1
Diastolic Heart Failure
08/2021
1
Heart Valve Diseases (Valvular Heart Disease)
08/2021
1
Anthracosis
09/2018
1
Fistula
12/2017
1
Cardiac Sudden Death (Sudden Cardiac Arrest)
03/2017
1
Cardiac Arrhythmias (Arrythmia)
01/2016
1
Hypersensitivity (Allergy)
01/2016
1
Myocardial Ischemia (Ischemic Heart Diseases)
10/2013
1
Pathologic Constriction (Stenosis)
10/2013
1
Ventricular Heart Septal Defects (Ventricular Septal Defect)
03/2010
1
Pain (Aches)
03/2010
1
Cardiogenic Shock
03/2010
1
Cardiovascular Diseases (Cardiovascular Disease)
03/2010
1
Cardiac Tamponade
03/2010
1
Reperfusion Injury
02/2009
1
Heart Neoplasms
03/2006
1
Atrial Fibrillation
04/2002
Drug/Important Bio-Agent (IBA)
3
RB 006
IBA
01/2016 - 08/2013
3
Heparin (Liquaemin)
FDA Link
Generic
08/2014 - 08/2013
2
Dobutamine
FDA Link
Generic
11/2021 - 04/2002
2
Factor IXa (Coagulation Factor IXa)
IBA
01/2016 - 08/2014
2
RB 007
IBA
01/2016 - 08/2014
1
Complement System Proteins (Complement)
IBA
01/2023
1
Esters
IBA
08/2021
1
salicylhydroxamic acid (SHAM)
IBA
03/2017
1
bivalirudin (Angiomax)
FDA Link
01/2016
1
Dipyridamole (Persantine)
FDA Link
Generic
10/2013
1
contrast agent BR1
IBA
10/2013
1
Vasodilator Agents (Vasodilators)
IBA
10/2013
1
Sulfur Hexafluoride
IBA
10/2013
1
Dichlorodiphenyldichloroethane (DDD)
IBA
03/2010
1
Peptides (Polypeptides)
IBA
02/2009
1
Fibrin
IBA
02/2009
1
Gadolinium
IBA
02/2009
1
Troponin I
IBA
02/2009
1
Anticoagulants
IBA
03/2006
1
Dystrophin
IBA
10/2003
Therapy/Procedure
5
Percutaneous Coronary Intervention
01/2020 - 02/2009
3
Therapeutics
10/2022 - 01/2016
2
Stents
12/2017 - 01/2016
1
Drug Therapy (Chemotherapy)
08/2021
1
Radiotherapy
08/2021
1
Surgical Instruments (Clip)
09/2018
1
Biological Therapy
03/2017
1
Cell- and Tissue-Based Therapy (Cell Therapy)
03/2017
1
Microbubbles
10/2013
1
Anticoagulation Reversal
08/2013
1
Counterpulsation (External Counterpulsation)
03/2010
1
Thrombolytic Therapy
06/2007
1
Heart Transplantation (Grafting, Heart)
04/2002